These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 33533261)

  • 1. Validation of the Chinese version of Addenbrooke's cognitive examination III for detecting mild cognitive impairment.
    Pan FF; Wang Y; Huang L; Huang Y; Guo QH
    Aging Ment Health; 2022 Feb; 26(2):384-391. PubMed ID: 33533261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a modified Chinese version of Mini-Addenbrooke's Cognitive Examination for detecting mild cognitive impairment.
    Pan FF; Cui L; Li QJ; Guo QH
    Brain Behav; 2022 Jan; 12(1):e2418. PubMed ID: 34843170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation Study of the Chinese Version of Addenbrooke's Cognitive Examination III for Diagnosing Mild Cognitive Impairment and Mild Dementia.
    Li X; Yang L; Yin J; Yu N; Ye F
    J Clin Neurol; 2019 Jul; 15(3):313-320. PubMed ID: 31286702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Chinese version of Addenbrooke's cognitive examination-revised for screening mild Alzheimer's disease and mild cognitive impairment.
    Fang R; Wang G; Huang Y; Zhuang JP; Tang HD; Wang Y; Deng YL; Xu W; Chen SD; Ren RJ
    Dement Geriatr Cogn Disord; 2014; 37(3-4):223-31. PubMed ID: 24193223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study on the validations of three cognitive screening tests in identifying subtle cognitive decline.
    Pan FF; Huang L; Chen KL; Zhao QH; Guo QH
    BMC Neurol; 2020 Mar; 20(1):78. PubMed ID: 32138678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of the Addenbrooke's Cognitive Examination - III (ACE-III), Mini-ACE, Mini-Mental State Examination, Montreal Cognitive Assessment, and Hasegawa Dementia Scale-Revised for detecting mild cognitive impairment and dementia.
    Senda M; Terada S; Takenoshita S; Hayashi S; Yabe M; Imai N; Horiuchi M; Yamada N
    Psychogeriatrics; 2020 Mar; 20(2):156-162. PubMed ID: 31448862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Cuban Version of Addenbrooke's Cognitive Examination-Revised for Screening Mild Cognitive Impairment.
    Broche-Pérez Y; López-Pujol HA
    Dement Geriatr Cogn Disord; 2017; 44(5-6):320-327. PubMed ID: 29393151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Validation Study of the Chinese Version of the Mini-Addenbrooke's Cognitive Examination for Screening Mild Cognitive Impairment and Mild Dementia.
    Yang L; Li X; Yin J; Yu N; Liu J; Ye F
    J Geriatr Psychiatry Neurol; 2019 Jul; 32(4):205-210. PubMed ID: 30987514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaption and preliminary validation of the Addenbrooke's Cognitive Examination-III as a screening test for mild cognitive impairment and dementia in hearing-impaired individuals.
    North C; Heatley MH; Utoomprurkporn N; Bamiou DE; Costafreda SG; Stott J
    Eur J Neurol; 2021 Jun; 28(6):1820-1828. PubMed ID: 33486875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Chinese Version of Montreal Cognitive Assessment Basic for Screening Mild Cognitive Impairment.
    Chen KL; Xu Y; Chu AQ; Ding D; Liang XN; Nasreddine ZS; Dong Q; Hong Z; Zhao QH; Guo QH
    J Am Geriatr Soc; 2016 Dec; 64(12):e285-e290. PubMed ID: 27996103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between handgrip strength and cognition in a Chinese population with Alzheimer's disease and mild cognitive impairment.
    Su H; Sun X; Li F; Guo Q
    BMC Geriatr; 2021 Aug; 21(1):459. PubMed ID: 34380435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Malay Version of Addenbrooke's Cognitive Examination III in Detecting Mild Cognitive Impairment and Dementia.
    Kan KC; Subramaniam P; Shahrizaila N; Kamaruzzaman SB; Razali R; Ghazali SE
    Dement Geriatr Cogn Dis Extra; 2019; 9(1):66-76. PubMed ID: 31043965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Portuguese version of Addenbrooke's Cognitive Examination III in mild cognitive impairment and dementia.
    Peixoto B; Machado M; Rocha P; Macedo C; Machado A; Baeta É; Gonçalves G; Pimentel P; Lopes E; Monteiro L
    Adv Clin Exp Med; 2018 Jun; 27(6):781-786. PubMed ID: 29790690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Mini-Addenbrooke's Cognitive Examination in Mild Cognitive Impairment in Arabic Speakers.
    Qassem T; Khater MS; Emara T; Rasheedy D; Tawfik HM; Mohammedin AS; Tolba MF; Aly El-Gabry D; Abdel Aziz K; Saber HG
    Dement Geriatr Cogn Disord; 2021; 50(2):178-182. PubMed ID: 34293741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of two Chinese versions of Montreal Cognitive Assessment for Screening of Mild Cognitive Impairment.
    Huang YY; Qian SX; Guan QB; Chen KL; Zhao QH; Lu JH; Guo QH
    Appl Neuropsychol Adult; 2021; 28(1):88-93. PubMed ID: 31014115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining Appropriate Screening Tools and Cutoffs for Cognitive Impairment in the Chinese Elderly.
    Zhang S; Qiu Q; Qian S; Lin X; Yan F; Sun L; Xiao S; Wang J; Fang Y; Li X
    Front Psychiatry; 2021; 12():773281. PubMed ID: 34925100
    [No Abstract]   [Full Text] [Related]  

  • 17. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration.
    Alexopoulos P; Ebert A; Richter-Schmidinger T; Schöll E; Natale B; Aguilar CA; Gourzis P; Weih M; Perneczky R; Diehl-Schmid J; Kneib T; Förstl H; Kurz A; Danek A; Kornhuber J
    Dement Geriatr Cogn Disord; 2010; 29(5):448-56. PubMed ID: 20502019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Diagnostic Accuracy of Five Cognitive Screening Tests for Diagnosing Mild Cognitive Impairment in Patients Consulting for Memory Loss.
    Valles-Salgado M; Matias-Guiu JA; Delgado-Álvarez A; Delgado-Alonso C; Gil-Moreno MJ; Valiente-Gordillo E; López-Carbonero JI; Fernández-Romero L; Peña-DeDiego L; Oliver-Mas S; Matías-Guiu J; Diez-Cirarda M
    J Clin Med; 2024 Aug; 13(16):. PubMed ID: 39200837
    [No Abstract]   [Full Text] [Related]  

  • 19. MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards Neuropsychological Battery after TIA and stroke.
    Pendlebury ST; Mariz J; Bull L; Mehta Z; Rothwell PM
    Stroke; 2012 Feb; 43(2):464-9. PubMed ID: 22156700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.